Reduced Dose Rituximab Is Effective in Recurrent Membranous Nephropathy

被引：0
|
作者：
Wagner, S. J. [1 ]
Saab, G. [1 ]
Java, A. [1 ]
Klein, C. [1 ]
Brennan, D. C. [1 ]
机构：
[1] Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1196
引用
收藏
页码：380 / 380
页数：1
相关论文
共 50 条
  • [1] Low-Dose Rituximab for Posttransplant Recurrent Membranous Nephropathy
    Cravedi, P.
    Ruggenenti, P.
    Remuzzi, G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1336 - 1336
  • [2] Low-dose rituximab is poorly effective in patients with primary membranous nephropathy
    Moroni, Gabriella
    Depetri, Federica
    Del Vecchio, Lucia
    Gallelli, Beniamina
    Raffiotta, Francesca
    Giglio, Elisa
    Brunini, Francesca
    D'Amico, Marco
    Longhi, Selena
    Radice, Antonella
    Messa, Piergiorgio
    Sinico, Renato Alberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (10) : 1691 - 1696
  • [3] Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy
    Pathak, Vivek
    Venkatesan, Madhav
    Regunathan-Shenk, Renu
    KIDNEY360, 2021, 2 (02): : 336 - 338
  • [4] Rituximab in Membranous Nephropathy
    Gauckler, Philipp
    Shin, Jae Il
    Alberici, Federico
    Audard, Vincent
    Bruchfeld, Annette
    Busch, Martin
    Cheung, Chee Kay
    Crnogorac, Matija
    Delbarba, Elisa
    Eller, Kathrin
    Faguer, Stanislas
    Galesic, Kresimir
    Griffin, Sian
    van den Hoogen, Martijn W. F.
    Hruskova, Zdenka
    Jeyabalan, Anushya
    Karras, Alexandre
    King, Catherine
    Kohli, Harbir Singh
    Mayer, Gert
    Maas, Rutger
    Muto, Masahiro
    Moiseev, Sergey
    Odler, Balazs
    Pepper, Ruth J.
    Quintana, Luis F.
    Radhakrishnan, Jai
    Ramachandran, Raja
    Salama, Alan D.
    Schonermarck, Ulf
    Segelmark, Marten
    Smith, Lee
    Tesar, Vladimir
    Wetzels, Jack
    Willcocks, Lisa
    Windpessl, Martin
    Zand, Ladan
    Zonozi, Reza
    Kronbichler, Andreas
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 881 - 893
  • [5] Rituximab in membranous nephropathy
    Ring, Troels
    KIDNEY INTERNATIONAL, 2008, 74 (03) : 391 - 392
  • [6] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, L., I
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [7] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, Li
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I632 - I632
  • [8] EARLY TREATMENT WITH RITUXIMAB IN RECURRENT MEMBRANOUS NEPHROPATHY AFTER KIDNEY TRANSPLANT
    Agrawal, Nikhil
    Adapa, Sreedhar
    Konala, Venu Madhav
    Dhingra, Hemant
    Pavlakis, Martha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 646 - 646
  • [9] Rituximab in Idiopathic Membranous Nephropathy
    Ruggenenti, Piero
    Cravedi, Paolo
    Chianca, Antonietta
    Perna, Annalisa
    Ruggiero, Barbara
    Gaspari, Flavio
    Rambaldi, Alessandro
    Marasa, Maddalena
    Remuzzi, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08): : 1416 - 1425
  • [10] Rituximab or Cyclosporine for Membranous Nephropathy
    Ponticelli, Claudio
    Moroni, Gabriella
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1688 - 1689
12345